These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 12702184)

  • 1. An evaluation of predictive factors for CD34+ cell harvest yields from patients mobilized with chemotherapy and growth factors.
    Ford CD; Chan KJ; Reilly WF; Petersen FB
    Transfusion; 2003 May; 43(5):622-5. PubMed ID: 12702184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved Prediction of CD34+ Cell Yield before Peripheral Blood Hematopoietic Progenitor Cell Collection Using a Modified Target Value-Tailored Approach.
    Sheppard D; Tay J; Palmer D; Xenocostas A; Doulaverakis C; Huebsch L; McDiarmid S; Tinmouth A; Mallick R; Martin L; Birch P; Hamelin L; Allan D; Bredeson C
    Biol Blood Marrow Transplant; 2016 Apr; 22(4):763-767. PubMed ID: 26643030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preharvest hematopoietic progenitor cell counts predict CD34+ cell yields in granulocyte-colony-stimulating factor-mobilized peripheral blood stem cell harvest in healthy donors.
    Yang SH; Wang TF; Tsai HH; Lin TY; Wen SH; Chen SH
    Transfusion; 2010 May; 50(5):1088-95. PubMed ID: 20051055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical usefulness of the hematopoietic progenitor cell counts in predicting the optimal timing of peripheral blood stem cell harvest.
    Lee JL; Kim SB; Lee GW; Ryu MH; Kim EK; Kim S; Kim WK; Lee JS; Park KU; Suh C
    J Korean Med Sci; 2003 Feb; 18(1):27-35. PubMed ID: 12589083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlations between hematopoietic progenitor cell counts as measured by Sysmex and CD34+ cell harvest yields following mobilization with different regimens.
    Vogel W; Kopp HG; Kanz L; Einsele H
    J Cancer Res Clin Oncol; 2002 Jul; 128(7):380-4. PubMed ID: 12136252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of hematocrit level for predicting the efficiency of peripheral blood CD34(+) cell collection after G-CSF Mobilization in Healthy Donors.
    Pornprasertsud N; Niparuck P; Kidkarn R; Puavilai T; Sirachainan N; Pakakasama S; Hongeng S; Jootar S; Ungkanont A
    J Clin Apher; 2015 Dec; 30(6):329-34. PubMed ID: 25663039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral blood progenitor cell collections in cancer patients: analysis of factors affecting the yields.
    Sautois B; Fraipont V; Baudoux E; Fassotte MF; Hermanne JP; Jérusalem G; Bours V; Bosquée L; Schaaf-Lafontaine N; Paulus JM; Sondag D; Fillet G; Beguin Y
    Haematologica; 1999 Apr; 84(4):342-9. PubMed ID: 10190949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of hematopoietic stem cell yield after mobilization with granulocyte-colony-stimulating factor in healthy unrelated donors.
    Teipel R; Schetelig J; Kramer M; Schmidt H; Schmidt AH; Thiede C; Oelschlägel U; Kroschinsky F; Bornhäuser M; Ehninger G; Hölig K
    Transfusion; 2015 Dec; 55(12):2855-63. PubMed ID: 26183707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Factors impacting yield of CD34(+) cells from healthy donors mobilized with rhG-CSF].
    Zhu L; Zhou LK; Xue M; Yan HM; Liu J; Wang ZD; Ding L; Wang HX
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Dec; 17(6):1541-5. PubMed ID: 20030943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of number of apheresis procedures necessary in healthy donors to attain minimally required peripheral blood CD34+ cells.
    Namba N; Matsuo K; Kubonishi S; Kikuchi T; Maeda Y; Niiya M; Shinagawa K; Koide N; Ikeda K; Tanimoto M
    Transfusion; 2009 Nov; 49(11):2384-9. PubMed ID: 19624602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors for successful PBSC collection on the fourth day of G-CSF-induced mobilization in allogeneic stem cell donors.
    van Oostrum A; Zwaginga JJ; Croockewit S; Overdevest J; Fechter M; Ruiterkamp B; Brand A; Netelenbos T
    J Clin Apher; 2017 Dec; 32(6):397-404. PubMed ID: 28139098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GM-CSF-based mobilization effect in normal healthy donors for allogeneic peripheral blood stem cell transplantation.
    Sohn SK; Kim JG; Seo KW; Chae YS; Jung JT; Suh JS; Lee KB
    Bone Marrow Transplant; 2002 Jul; 30(2):81-6. PubMed ID: 12132046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors associated with peripheral blood stem cell yield in volunteer donors mobilized with granulocyte colony-stimulating factors: the impact of donor characteristics and procedural settings.
    Wang TF; Wen SH; Chen RL; Lu CJ; Zheng YJ; Yang SH; Chu SC; Kao RH; Chen SH
    Biol Blood Marrow Transplant; 2008 Nov; 14(11):1305-11. PubMed ID: 18940686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated transforming growth factor beta levels in the plasma of cytokine-treated cancer patients and normal allogeneic stem cell donors.
    McGuire TR; Kessinger A; Hock L; Sharp JG
    Cytotherapy; 2001; 3(5):361-4. PubMed ID: 11953015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripheral blood circulating immature cell counts predict CD34+ cell yields in G-CSF-induced PBPC mobilization in healthy donors.
    Kozuka T; Ikeda K; Teshima T; Yoshida C; Shinagawa K; Kojima K; Matsuo K; Bessho A; Sunami K; Hiramatsu Y; Maeda Y; Noguchi T; Yamamoto K; Fujii N; Imai T; Kusumoto KK; Masuda K; Takenaka K; Ishimaru F; Niiya K; Koide N; Tanimoto M; Harada M
    Transfusion; 2004 Apr; 44(4):526-32. PubMed ID: 15043568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of G-CSF on peripheral blood progenitor cell mobilization and collection from healthy donors.
    Chaisiripoomkere W; Jootar S; Ungkanont A
    Asian Pac J Allergy Immunol; 2001 Sep; 19(3):183-90. PubMed ID: 11826913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Donor body mass index is an important factor that affects peripheral blood progenitor cell yield in healthy donors after mobilization with granulocyte-colony-stimulating factor.
    Chen J; Burns KM; Babic A; Carrum G; Kennedy M; Segura FJ; Garcia S; Potts S; Leveque C
    Transfusion; 2014 Jan; 54(1):203-10. PubMed ID: 23763340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of CD34+ cell collection efficiency on the COBE Spectra and Fenwal CS-3000 Plus.
    Ford CD; Lehman C; Strupp A; Kelley L
    J Clin Apher; 2002; 17(1):17-20. PubMed ID: 11948701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of apheresis content of progenitor cell collections from normal donors to whom granulocyte-colony-stimulating factor is administered.
    Weinthal JA; Nemunaitis JJ; Aston S; Magsamen MJ; Rosenfeld CS
    Transfusion; 1996; 36(11-12):943-7. PubMed ID: 8937400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mobilization of peripheral blood stem cells following myelosuppressive chemotherapy: a randomized comparison of filgrastim, sargramostim, or sequential sargramostim and filgrastim.
    Weaver CH; Schulman KA; Buckner CD
    Bone Marrow Transplant; 2001 May; 27 Suppl 2():S23-9. PubMed ID: 11436117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.